Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the PLEC gene causes a rare condition with skin blistering, muscle weakness, and hair loss.

HPV does not cause aggressive cancer in RDEB patients.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

Scientists created a cell model to study and find treatments for a skin disease called RDEB.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Injecting specific cells into the skin can help improve skin structure and reduce blisters in a genetic skin disorder.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

A girl with red hair developed hair-pulling and body image disorders after being bullied for her hair color.

Localized dystrophic epidermolysis bullosa (DEB) can lead to scarring alopecia, highlighting the need to recognize and address this complication.

Scalp hair follicle cells help protect and heal skin in certain skin conditions.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Accurate diagnosis of RDEB-mitis in older adults is crucial for proper management without immunosuppressants.

Scientists created cell lines to study a genetic skin disorder using CRISPR technology.

Most Recessive Dystrophic Epidermolysis Bullosa patients with a specific mutation likely have Sephardic ancestry from about 500 years ago.

Researchers fixed gene mutations causing a skin disease in stem cells, which then improved skin grafts in mice.

Skin grafts from related donors significantly healed chronic wounds in patients with a severe skin condition over a year.

Mutations in Far2 mice cause hair loss due to sebaceous gland issues.

People with myotonic dystrophy type 1 have a higher chance of getting skin tumors, including melanoma.

A woman with myotonic dystrophy had multiple skin tumors on her scalp, suggesting a genetic link.

People with Myotonic Dystrophy type 1 are more likely to have certain skin conditions, but not more likely to get skin cancer.

Women with myotonic dystrophy might get diseases related to male hormones because their body tissues are extra sensitive to these hormones.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

A man with myotonic dystrophy type 1 had 28 skin cancers, suggesting a link between the disease and skin cancer, emphasizing the need for sun protection and regular skin checks.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

The angora mouse mutation causes long hair and hair defects due to a gene deletion.

Myotonic dystrophy may be classified as a segmental progeroid disorder.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

A new CDH3 gene mutation was found in a Spanish patient with sparse hair and eye issues.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.